Filing Details
- Accession Number:
- 0001104659-21-048831
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-09 17:25:28
- Reporting Period:
- 2021-01-01
- Accepted Time:
- 2021-04-09 17:25:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1429260 | Fortress Biotech Inc. | FBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1318886 | K Eric Rowinsky | C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2021-01-01 | 100,000 | $0.00 | 750,000 | No | 4 | A | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2021-02-05 | 4,000 | $3.80 | 746,000 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2021-02-16 | 2,000 | $3.86 | 744,000 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2021-02-18 | 6,000 | $4.20 | 738,000 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2021-02-19 | 8,000 | $4.31 | 730,000 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2021-03-02 | 10,000 | $4.45 | 720,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Annual grant of restricted shares of Issuer stock to members of the Issuer's Board of Directors. One-third of the shares will vest on each January 1, 2022, 2023 and 2024, subject to continued service.
- In connection with the vesting of 100,000 shares on January 1, 2021, a total of 30,000 shares were sold by the Reporting Person in order to satisfy the Reporting Person's tax withholding obligations.
- Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on February 5, 2021, was $3.75 to $3.84.*
- Reflects an open market sale transaction effected by the Reporting Person through a sale order executed by a broker-dealer.*
- Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on February 18, 2021, was $4.19 to $4.23.*
- Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on February 19, 2021, was $4.30 to $4.31.*
- Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 2, 2021, was $4.40 to $4.50.*
Billionaire Hedge Funds
